Unwanted Advice? Frequency, Characteristics, And Outcomes Of Negative Advisory Committee Votes For FDA-Approved Drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Unwanted Advice? Frequency, Characteristics, And Outcomes Of Negative Advisory Committee Votes For FDA-Approved Drugs

Published:2022-05-01 Issue:5 Volume:41 Page:713-721
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Daval C. Joseph Ross¹,Sarpatwari Ameet²,Kesselheim Aaron S.³

Affiliation:

1. C. Joseph Ross Daval, Brigham and Women’s Hospital and Harvard University, Boston, Massachusetts.

2. Ameet Sarpatwari, Brigham and Women’s Hospital and Harvard University.

3. Aaron S. Kesselheim (), Brigham and Women’s Hospital and Harvard University.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference13 articles.

1. Product Approvability Recommendations From FDA Advisory Committees: Inconsistently Sought, Indirectly Obtained

2. Federal Advisory Committees, Policy Expertise, and the Approval of Drugs and Medical Devices at the FDA

3. Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008–2015

4. Oncology Drug Advisory Committee Recommendations and the US Food and Drug Administration’s Actions

5. Promoting Agency Reputation through Public Advice: Advisory Committee Use in the FDA

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unease as US drug agency weighs its use of independent scientists;Nature;2024-06-14

2. Capitalizing on Hope: Questionable Marketing Approval and Pricing of a New ALS Drug;International Journal of Social Determinants of Health and Health Services;2024-04-22

3. Independent Advice on Drug Approvals: an Investigation of EMA Practices;Journal of General Internal Medicine;2023-10-30

4. Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines;Hastings Center Report;2023-09

5. Improving Food and Drug Administration–Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval;The Milbank Quarterly;2023-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3